Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Depression Clinical Trials

A listing of Depression medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (34) clinical trials

The PAREXEL® Early Phase Unit located in Glendale, CA is looking for people with depression to participate in a clinical research study. TO QUALIFY YOU MUST BE: Male or female 18-59 years of age Have an existing diagnosis of Major Depressive Disorder Stable on antidepressants for 6 weeks The study ...

Phase

The California Clinical Trials Medical Group managed by PAREXEL, located in Glendale, CA is currently looking for volunteers with Major Depressive Disorder to participate in a clinical research study.

Phase

The California Clinical Trials Medical Group managed by PAREXEL, LOCATED IN Glendale, CA is currently looking for volunteers with Major Depressive Disorder to participate in a clinical research study.

Phase

The Study About Mechanism of Transcranial Magnetic Stimulation Treatment of Depression Using Medical Imaging

The advantages of 3D T1 WI are thin slice scanno interval, scanning fast and three-dimension reconstruction in any orientation compared with 2D SE. It is not easy to miss small lesions, and shows normal anatomy and lesions more objectively and more accurately. Doppler tissue imaging (DTI) can reflect white matter ...

Phase

Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subjects

This study evaluates the safety, tolerability and pharmacokinetics of Ammoxetine Hydrochloride Enteric-coated Tablets in Chinese heathy subjects. Part of the participants will receive Ammoxetine Hydrochloride Enteric-coated Tablets, while the other part will receive placebo.

Phase

CM Delivered PST in LLD Pilot

The study will be a single-centre, open-label, longitudinal, pragmatic, pilot trial. Research participants at this site will be 40 men and women between the ages of 60 and 85 who have mild to moderate major depressive disorder (MDD). Participants will be recruited from primary, secondary and tertiary care centres in ...

Phase

Trial of OnabotulinumtoxinA for Depression in Parkinson Disease

Depression is a common, but treatable, comorbid condition often seen in persons with Idiopathic Parkinson Disease (iPD). Depression in Parkinson Disease may be hard to treat as patients with iPD may be sensitive to side effect of medication. As a result, other treatments which have better side effects profiles than ...

Phase

Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant Depression

This is a phase I study, with eight subjects in the pilot phase and eighty (80) subjects fulfilling all inclusion/exclusion criteria's will be randomly assigned to receive allogeneic Human Mesenchymal Stem Cell (hMSCs) or placebo in a 1:1 blinded fashion. The 8 subjects in the pilot phase will receive a ...

Phase

Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations

Social cognitive impairments, particularly deficits and distortions in recognition and interpretation of social cues and representations of thoughts, intentions, and feelings of otherstermed mentalizationare a key contributor to the pathology and morbidity of a number of psychiatric disorders, including the schizophrenia spectrum, the autism spectrum and personality disorders. Individuals with ...

Phase

Ketamine as an Adjunctive Therapy for Major Depression

Pragmatic, randomised, controlled, parallel-group, pilot trial. Trial participants will be patients admitted to St Patrick's University Hospital for treatment of a depressive episode. The investigators aim to recruit up to 20 participants who will be eligible for this study and randomly allocate 10 patients to each group. The participants will ...

Phase